title: Activation of interictal spiking in mesiotemporal lobe epilepsy by propofol-induced sleep.
abstract: The objective of this study was to test whether low-dose propofol increases the number of interictal spikes in patients with mesiotemporal lobe epilepsy, and to determine whether this is the result of intrinsic properties and is restricted to the primary epileptogenic focus. Controlled infusion of propofol in step-up/-down target concentrations of 0, 0.3, 0.6, and 0.8 mg/L was administered to 10 patients during a 3.5-hour daytime EEG registration. The number of spikes were counted and related to propofol concentration and sleep level. Results were compared with a spontaneous, nocturnal first sleep cycle in 9 of 10 patients. All patients entered nonrapid eye movement 1 sleep during propofol administration, and 8 reached nonrapid eye movement 2 sleep. In 7 patients who showed spikes, spikes were related to sleep (P < 0.05) and not to increasing (P = 0.1) or decreasing (P = 0.5) propofol concentration. Six of nine patients showed more spikes during spontaneous (nocturnal) sleep than during propofol-induced sleep. Contralateral spiking was not suppressed selectively. Low-dose propofol is a safe means of increasing spiking in these patients because it induces sleep. There were no signs of an intrinsic epileptogenicity of propofol or a selective effect on ipsilateral spikes. Controlled sleep induction will increase the yield of interictal spikes during short interictal recordings such as in magnetoencephalography.
authors.affiliation: Department of Clinical Neurophysiology, University Medical Centre, Utrecht, The Netherlands.
authors.forename: F S
authors.initials: FS
authors.lastname: Leijten
authors.forename: N W
authors.initials: NW
authors.lastname: Teunissen
authors.forename: G H
authors.initials: GH
authors.lastname: Wieneke
authors.forename: J T
authors.initials: JT
authors.lastname: Knape
authors.forename: A F
authors.initials: AF
authors.lastname: Schobben
authors.forename: A C
authors.initials: AC
authors.lastname: van Huffelen
mesh_terms: D000328:Adult; D001931:Brain Mapping; D004292:Dominance, Cerebral / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography / Q000187:drug effects*; D004833:Epilepsy, Temporal Lobe / Q000175:diagnosis* / Q000503:physiopathology / Q000601:surgery; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008432:Mathematical Computing; D008875:Middle Aged; D017286:Polysomnography; D015742:Propofol; D012815:Signal Processing, Computer-Assisted; D012894:Sleep Stages / Q000187:drug effects* / Q000502:physiology; D013702:Temporal Lobe / Q000187:drug effects / Q000503:physiopathology
chemical_list: D015742:Propofol